UPDATE - Barclays Initiates Coverage on Rexnord (RXN) with an Overweight; Five Reasons To Like This Story
Tweet Send to a FriendGet Alerts RXN Hot Sheet
Price: $17.83 --0%
Rating Summary:
2 Buy, 5 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 6
Rating Summary:
2 Buy, 5 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 6
Trade RXN Now!
UPDATE - Barclays initiates coverage on Rexnord (NYSE: RXN) with an Overweight. PT $26.00.
Analyst, Scott R. Davis, said, "With long-term potential for value creation in the neighborhood of names like Roper (NYSE: ROP), Danaher (NYSE: DHR), Ametek (NYSE: AME), and IDEX (NYSE: IEX), Rexnord (RXN) could be one of the most interesting special situation stocks that we now cover. The company has multiple value creating levels and none of them appears to be overly heroic. There is risk for sure but upside if RXN gets it right will likely be outsized."
Davis points to five particular drivers for the stock: 1) Core businesses have plenty of tailwinds through 2014; 2) higher incremental margins; 3) Look for RXN to increase leverage and pay down debt; and 4) Market ripe for consolidation, so bolt-on or larger acquisition may be in the cards; and 5) Young, aggressive management team.
To see more ratings on RXN, Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Scott R. Davis, said, "With long-term potential for value creation in the neighborhood of names like Roper (NYSE: ROP), Danaher (NYSE: DHR), Ametek (NYSE: AME), and IDEX (NYSE: IEX), Rexnord (RXN) could be one of the most interesting special situation stocks that we now cover. The company has multiple value creating levels and none of them appears to be overly heroic. There is risk for sure but upside if RXN gets it right will likely be outsized."
Davis points to five particular drivers for the stock: 1) Core businesses have plenty of tailwinds through 2014; 2) higher incremental margins; 3) Look for RXN to increase leverage and pay down debt; and 4) Market ripe for consolidation, so bolt-on or larger acquisition may be in the cards; and 5) Young, aggressive management team.
To see more ratings on RXN, Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Michael Kors (KORS) Under-Appreciated; Canaccord Genuity Starts at Buy
- Piper Jaffray Starts LeapFrog (LF) at Overweight
- Wells Fargo Starts Taylor Morrison Home (TMHC) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Barclays
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
